YDES Stock Analysis: Buy, Sell, or Hold?
YDES - YD Bio Limited Ordinary Shares
$7.11
1.38 (24.08%)
▲
5d:
+170.34%
30d:
+83.72%
90d:
+193.8%
WAIT
LOW Confidence
Analysis Updated: Sep 28, 2026 12:00 AM ET
Get Alerted When YDES Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: YDES is 54.9% above its trading range ($4.59). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: YDES is 54.9% above its trading range ($4.59). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: YDES is currently trading at $7.11, which is considered extended relative to its 30-day fair value range of $3.33 to $4.59.
Technical Outlook: Technically, YDES is showing sideways momentum. Immediate support is located at $2.42, while resistance sits at $7.35. The stock is showing strong short-term momentum, up 24.1% recently.
Market Sentiment: YDES scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, YDES is showing sideways momentum. Immediate support is located at $2.42, while resistance sits at $7.35. The stock is showing strong short-term momentum, up 24.1% recently.
Market Sentiment: YDES scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.33 -
$4.59
Company Quality Score
38/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
5.9%
All Signals
- BEARISH: Price significantly overextended (+54.9% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: Strong upward momentum (+24.1%)
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.33 -
$4.59
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.42
Resistance Level
$7.35
Current Trend
Sideways
Technical data as of
Sep 28, 2026
Fundamental Context
Revenue Growth (YoY)
314.9%
Profit Margin
24.7%
Share & Embed Analysis
Last updated: September 28, 2026 4:26 PM ET
Data refreshes hourly during market hours. Next update: 5:26 PM
Data refreshes hourly during market hours. Next update: 5:26 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is YDES showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 54 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1180 | 67 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$47 | 59 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 43 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$118 | 65 BUY |